International Psoriasis Council

Did you know the Global Psoriasis Atlas (#GPA) issues a quarterly newsletter? Check out this quarter's issue: https://lnkd.in/gRCpJEmY Subscribe to the GPA: https://lnkd.in/eD__Br2i #IPCComunity #PsoriasisNews

?? Today, the GPA team had the pleasure of hosting International Psoriasis Council Fellow Dr. Bryan Guevara, along with The International League of Dermatological Societies (ILDS) CEO Arpita Bhose and ILDS Global Skin Health Project Coordinator Jennifer Kilmer. ? We have spent a productive day engaging in meetings sharing updates on the GPA’s latest research, ongoing collaborations, and exciting future projects.? ? #Collaboration #Dermatology #GlobalHealth #GPAResearch

See if you were correct on yesterday's #psoriasis poll ?? The answer was... B. Bimekizumab

?? New Congress Report now available from the 53rd Annual European Society for Dermatological Research (#ESDR) Meeting! In this report, 2023 #IPCFellow Francis Lai has compiled summaries from 18 presentations focusing on #psoriasis, including the #IPC & IEC Joint Symposium: From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis and Eczema. Don't miss the latest psoriasis updates from #ESDR2024. Read the summary or download the full report: https://lnkd.in/gsMH3tXT #IPCCongressReport #PsoriasisNews

?? A warm welcome to IPC Fellow Dr. Bryan Guevara, who is visiting GPA team in Manchester this week as part of his IPC Fellowship. Over the next few days, Dr. Guevara will be spending time with Prof Darren Ashcroft, Prof Chris Griffiths & the GPA team, visiting Manchester and London. Dr. Guevara is a board-certified dermatologist and dermatopathologist from the Southern Philippines Medical Center (government hospital) and Southeast Dermatology (private practice). He is actively involved in psoriasis research and clinical trials, including studies on generalized pustular psoriasis. We’re excited to have Dr. Guevara with us and look forward to collaborating on psoriasis research! #Welcome #Dermatology #PsoriasisResearch #GPAteam

Next year, IFPA will host a forum in Bogotá, Colombia, bringing together stakeholders from across the #psoriasis community to drive regional action. Focused on the Americas, this event will address the needs of psoriasis patients across the region. Stay tuned for updates from #IFPA: https://lnkd.in/deEsPUNx #PsoriasisCommunity #PsoriasisAdvocacy #PsoriasisEducation

?? Test your #psoriasis knowledge: Which of the following medications has the highest likelihood of treatment success in palmoplantar psoriasis? A. Apremilast B. Bimekizumab C. Ixekizumab D. Secukinumab Come back tomorrow for the correct answer! #PsoriasisEducation

?? This #WorldChildrensDay, the International Psoriasis Council (#IPC) would like to highlight the importance of supporting children with #psoriasis. Explore our expert resources on pediatric psoriasis to better understand and address their unique needs. https://lnkd.in/gWZF8YCU #PediatricPsoriasis #PsoriasisCare #WorldChildrensDay2024

Congratulations to 2024 #IPCFellow Bryan Guevara for receiving a 2025 Young Dermatologist International Achievement (YDIA) Award from The International League of Dermatological Societies (#ILDS). He joins an exclusive group of six people who are being recognized for their contribution to supporting people with skin disease. For more on Dr. Guevara's work, visit: https://lnkd.in/gcsX-_ve #IPCCommunity #PsoriasisExpert #YoungDermatologist

The GUIDE Study explores whether reducing treatment frequency could benefit patients who achieve an early, complete response, using biomarkers to track pathophysiological changes. Join 2022 #IPCFellow Leandro Leite as he shares expert commentary on this new data and discusses how further research could support dose-reduction protocols, opening new possibilities in chronic #psoriasismanagement. Read the full commentary, and continue the conversation in the comments on the #IPCWebsite: https://lnkd.in/gwitkNQf #PsoriasisExpert #PsoriasisTrial #IPCCommunity